SCHEMBL422564

SCHEMBL422564

CC(C)Cn1cc[n+](C)c1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.46
MEN1 O00255 1/20 0.46
APAF1 O14727 1/20 0.46
NPC1 O15118 1/20 0.46
PLA2G1B P04054 1/20 0.46
HSP90AA1 P07900 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ATG4B Q9Y4P1 1/20 0.46
LMNA P02545 1/20 0.37
PON1 P27169 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL4277562 0.98 FDPS (0.49) FDPSSMN1; SMN2MEN1APAF1NPC1
Bromide SCHEMBL22233104 0.98 FDPS (0.49) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL1071507 0.92 FDPS (0.45) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL29530839 0.89 FDPS (0.50) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL710181 0.84 FDPS (0.40) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL2527712 0.83 FDPS (0.51) FDPSSMN1; SMN2MEN1APAF1NPC1
Bromide SCHEMBL20138583 0.81 FDPS (0.46) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL5944483 0.81 FDPS (0.46) FDPSSMN1; SMN2MEN1APAF1NPC1
Hydrochloric Acid SCHEMBL6242021 0.81 FDPS (0.50) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL17764764 0.80 FDPS (0.53) FDPSSMN1; SMN2MEN1APAF1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220161250-A1 CO-DEFLAGRATION SYNTHESIS OF METALLIC, CERAMIC, AND MIXED CERAMIC-METALLIC PARTICLES TECH INNOVATION MOMENTUM FUND ISRAEL LIMITED PARTNERSHIP (IL) 2022-05-26 US claimed
EP-3946728-A1 CO-DEFLAGRATION SYNTHESIS OF METALLIC, CERAMIC, AND MIXED CERAMIC-METALLIC PARTICLES Technology Innovation Momentum Fund (Israel) Limited Partnership (IL) 2022-02-09 EP claimed
CN-107683349-B Pre-rinse containing quaternary amine for conditioning prior to conversion treatment 汉高股份有限及两合公司 2020-05-26 CN claimed
EP-3303652-B1 PRE-RINSE CONTAINING A QUATERNARY AMINE FOR CONDITIONING PRIOR TO A CONVERSION TREATMENT HENKEL AG & CO KGAA (DE) 2019-11-20 EP claimed
EP-3303652-A1 PRE-RINSE CONTAINING A QUATERNARY AMINE FOR CONDITIONING PRIOR TO A CONVERSION TREATMENT Henkel AG & Co. KGaA (DE) 2018-04-11 EP claimed
US-20180066365-A1 PRE-RINSE CONTAINING A QUATERNARY AMINE FOR CONDITIONING PRIOR TO A CONVERSION TREATMENT HENKEL AG & CO. KGAA (DE) 2018-03-08 US claimed
WO-2016193004-A1 CONDITIONING PRIOR TO A CONVERSION TREATMENT OF METAL SURFACES HENKEL AG & CO. KGAA (DE) 2016-12-08 WO claimed
WO-2016193005-A1 PRE-RINSE CONTAINING A QUATERNARY AMINE FOR CONDITIONING PRIOR TO A CONVERSION TREATMENT HENKEL AG & CO. KGAA (DE) 2016-12-08 WO claimed
EP-1087412-B1 Electrolyte composition, photosensitized solar cell using said electrolyte composition, and method of manufacturing photosensitized solar cell TOSHIBA KK (JP) 2008-10-01 EP claimed
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof WILLIAMS RICHARD KENT (US) 2026-04-30 US disclosed
US-11996557-B2 Direct regeneration of lithium ion cathodes by ionothermal relithiation UT-BATTELLE, LLC (US) 2024-05-28 US disclosed
US-11795583-B2 Plasticized melt spinning process using ionic liquids for production of polyacrylonitrile fibers UT-BATTELLE, LLC (US) 2023-10-24 US disclosed
US-20220376240-A1 DIRECT REGENERATION OF LITHIUM ION CATHODES BY IONOTHERMAL RELITHIATION U. S. DEPARTMENT OF ENERGY 2022-11-24 US disclosed
US-20220235493-A1 PLASTICIZED MELT SPINNING PROCESS USING IONIC LIQUIDS FOR PRODUCTION OF POLYACRYLONITRILE FIBERS UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2022-07-28 US disclosed
EP-1981034-A1 ACTUATOR ELEMENT Daikin Industries, Ltd. (JP) 2008-10-15 EP disclosed
US-20080064898-A1 Method for Producing Oxygen-Containing Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-03-13 US disclosed
US-20070219379-A1 Ionic Liquid and Process for Producing the Same KANEKA CORPORATION (JP) 2007-09-20 US disclosed
EP-1797953-A1 PROCESS FOR PRODUCING OXYGENIC COMPOUND Sumitomo Chemical Company, Limited (JP) 2007-06-20 EP disclosed
US-20060186419-A1 Light-emitting device KABUSHIKI KAISHA TOSHIBA (JP) 2006-08-24 US disclosed
EP-0737358-B1 PHOTOELECTROCHEMICAL CELL AND ELECTROLYTE THEREFOR ECOLE POLYTECH (CH) 1999-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064898-A1 Method for Producing Oxygen-Containing Compound AOC2, AOX1, CAT FDPS 1352/4885SMN1; SMN2 882/4885MEN1 2767/4885
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof MYOC, MB, MYOF FDPS 3650/4885SMN1; SMN2 46/4885MEN1 1273/4885
US-20070219379-A1 Ionic Liquid and Process for Producing the Same HCN4, HCN2, HCN3 FDPS 110/4885SMN1; SMN2 3824/4885MEN1 3967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.